Down syndrome (trisomy 21) is associated with developmental and intellectual delays, ranging from mild to severe
Edwards syndrome (trisomy 18) is a condition that causes severe developmental delays and birth defects
Patau syndrome (trisomy 13) is a condition that causes severe intellectual disability and physical defects.
Additional screening for the following sex chromosome conditions can be requested at no additional cost:
Routine, non-invasive blood draw, from the mother, requiring just one tube of blood (7–10 ml).
Directly analyzes cell-free fetal and maternal DNA with our proprietary Safer algorithm; very low failure rate (0.1%).
Test as early as 10 weeks (gestational age). No limitations regarding ethnicity, BMI, ART or egg donor cases.
Results reported to provider 7-10 days after sample receipt. (Time to report may vary based on partner laboratory providing the test.)
A report with your results is provided to your physician with 3 possible outcomes
Both “aneuploidy suspected (borderline value)” and “aneuploidy detected” results should be confirmed by an invasive procedure if a more definitive diagnosis is desired.
Contact the distributor at the bottom of this page
Physician or lab personnel collect your sample
Your sample gets processed at VeritasGenetics’ CLIA lab
VeritasGenetics interprets your results and provides a report to your physician
Superior technology for informative non-invasive prenatal screening
myPrenatal uses an advanced technology called “Massively Parallel Sequencing” to analyze millions of DNA fragments per sample and accurately count the number of chromosomes present. It then uses a special Safer calculation method to determine if there are too many or too few copies of these chromosomes in your baby.
VeritasGenetics is a global pioneer in disease prevention through accessible genetic information. By removing the barriers to genetic screening, Veritas empowers individuals and doctors to make informed lifestyle decisions that can lead to disease prevention and longer and healthier lives. Veritas is founded by leaders in genomics from Harvard Medical School and operates globally from its offices in the U.S., Europe and China.